Breast Cancer Antibodies from Tumor-Infiltrating B Lymphocytes
Author Information
Author(s): Pavoni Emiliano, Monteriù Giorgia, Santapaola Daniela, Petronzelli Fiorella, Anastasi Anna Maria, Pelliccia Angela, D'Alessio Valeria, De Santis Rita, Minenkova Olga
Primary Institution: Kenton Srl, c/o Sigma-Tau SpA, Italy
Hypothesis
Can tumor-infiltrating B lymphocytes provide a source of specific antibodies recognizing tumor cells in breast cancer patients?
Conclusion
The study shows that tumor-infiltrating B lymphocytes can generate specific antibodies against tumor antigens in breast cancer patients.
Supporting Evidence
- Seven out of ten tumor specimens showed oligoclonal antibody responses.
- Specific antibodies were isolated from libraries derived from tumor-infiltrating B lymphocytes.
- Antibodies recognized both purified tumor antigens and living breast carcinoma cells.
Takeaway
Doctors can find special proteins in breast cancer patients' tumors that help the body fight the cancer.
Methodology
The study analyzed antibodies from tumor-infiltrating lymphocytes and created recombinant antibody libraries to identify specific antibodies against tumor antigens.
Potential Biases
Potential bias due to the limited diversity of the antibody libraries derived from a small number of patients.
Limitations
The study was limited by the small sample size and the specific patient demographics.
Participant Demographics
Patients aged 47 to 79 with breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website